What is it about?
The aim of this study was to investigate if the expression of CD105 and Ets‐1 was predictive of aggressive biologic behavior of non‐melanoma skin cancers (NMSC) and to evaluate indicators of local recurrence.
Featured Image
Why is it important?
Valuable prognostic marker for non-melanoma skin cancers
Read the Original
This page is a summary of: The impact of Ets-1 oncoprotein and human endoglin (CD105) on the recurrence of non-melanoma skin cancers, International Journal of Dermatology, July 2015, Wiley,
DOI: 10.1111/ijd.12891.
You can read the full text:
Contributors
The following have contributed to this page
